Robert F O'Reilly from Cleveland, OH, age 40

Medicine Doctors

Robert C. O'reilly

view source

Specialties:

Pediatric Otolaryngology

Work:

Nemours Children's Health SystemNemours Childrens Clinic
3855 W Chester Pike STE 280, Newtown Square, PA 19073
610 557-4800 (phone), 610 557-4816 (fax)

Nemours Children's Health SystemNemours duPont Pediatrics Bryn Mawr
825 Old Lancaster Rd STE 250, Bryn Mawr, PA 19010
610 542-3300 (phone), 610 542-3320 (fax)

Education:

Medical School
Thomas Jefferson University, Jefferson Medical College
Graduated: 1990

Procedures:

Myringotomy and Tympanotomy
Sinus Surgery
Skull/Facial Bone Fractures and Dislocations
Tonsillectomy or Adenoidectomy
Tympanoplasty

Conditions:

Acute Upper Respiratory Tract Infections
Obstructive Sleep Apnea
Otitis Media
Acute Pharyngitis
Acute Sinusitis

Languages:

English
Spanish

Description:

Dr. O'reilly graduated from the Thomas Jefferson University, Jefferson Medical College in 1990. He works in Bryn Mawr, PA and 1 other location and specializes in Pediatric Otolaryngology. Dr. O'reilly is affiliated with Bryn Mawr Hospital and Nemours Alfred I duPont Hospital For Children.

Robert M. O'reilly

view source

Specialties:

Internal Medicine

Work:

Franklin Community HealthFranklin Health Internal Medicine
131 Franklin Health Cmns STE F, Farmington, ME 04938
207 778-4922 (phone), 207 779-0646 (fax)

Education:

Medical School
A.T. Still University of Health Sciences/ Kirksville College of Osteopathic Medicine
Graduated: 1979

Languages:

English

Description:

Dr. O'Reilly graduated from the A.T. Still University of Health Sciences/ Kirksville College of Osteopathic Medicine in 1979. He works in Farmington, ME and specializes in Internal Medicine. Dr. O'Reilly is affiliated with Franklin Memorial Hospital.

Resumes

Robert O'reilly

view source

Robert O'reilly

view source

Robert O'reilly

view source

Robert O'reilly

view source

Robert O'reilly

view source

Robert O'reilly Sarasota, FL

view source

Work:

SAFE MONEY SOLUTIONS

Jan 2008 to 2000
Owner/Manager AMERI-LIFE AND HEALTH INSURANCE
Venice, FL
Feb 2004 to Dec 2008
State Director - Florida AMERI-LIFE AND HEALTH INSURANCE
Sarasota, FL
Feb 1994 to Jan 2004
BUSINESS DEVELOPEMENT AND SALES DIRECTOR AMERI-LIFE AND HEALTH INSURANCE
Charlotte, NC
Nov 1990 to Jan 1994
State Director of North Carolina AMERI-LIFE AND HEALTH INSURANCE
Bradenton, FL
Jun 1988 to Oct 1990
Assistant Manager Bob Barkley Toyota / Teimpleton Toyota
Sarasota, FL
Feb 1983 to Nov 1988
Automotive Sales

Education:

Life and Health Insurance School of Cleveland, Oh., Charlotte, N.C. and Tampa, Fl.
Charlotte, NC
1974 to 2013
Licensed Life and Health Insurance Agent for Florida, North Carolina and Ohio in The laws, practices and ethics of all forms of insurance Lakeland College
Cleveland, OH
1986
Licensed Insurance Agent

Skills:

Recruiting, Training and Maintaining over 1000 insurance agents. Human Relations Manager - State of Florida

Lawyers & Attorneys

Robert O'Reilly - Lawyer

view source

Specialties:

Probate & Estate Planning
Estate Planning
Environmental Law
Probate
Trusts
Wills & Living Wills
Probate
Trusts

ISLN:

1000057534

Admitted:

2012

Law School:

Wayne State University Law School, JD - Juris Doctor, 2012

Us Patents

Method And Device For Treating Dysfunctional Cardiac Tissue
view source
US Patent:

8506474, Aug 13, 2013
Filed:

Aug 21, 2006
Appl. No.:

11/507146
Inventors:

Lon Annest - New York NY, US
Robert O'Reilly - Lafayette CA, US
Assignee:

BioVentrix, Inc. - San Ramon CA
International Classification:

A61F 2/00
US Classification:

600 37, 600 16
Abstract:

Various methods and devices are provided for reducing the volume of the ventricles of the heart. In one embodiment, a method for reducing the ventricular volume of a heart chamber is provided including the steps of inserting an anchoring mechanism onto dysfunctional cardiac tissue, deploying one or more anchors into the dysfunctional cardiac tissue, raising the dysfunctional cardiac tissue using the anchors, and securing the anchors to hold the dysfunctional cardiac tissue in place. Further, a device for reducing the volume of the ventricles of a heart chamber is provided where the device has one or more clips for placement on dysfunctional cardiac tissue of a heart, one or more anchors for deployment and securement into the dysfunctional cardiac tissue, and a lifting mechanism for raising the one or more anchors and the dysfunctional cardiac tissue.

Method And Device For Treating Dysfunctional Cardiac Tissue
view source
US Patent:

20140051916, Feb 20, 2014
Filed:

Aug 13, 2013
Appl. No.:

13/966049
Inventors:

Lon Annest - New York NY, US
Robert O'Reilly - Lafayette CA, US
Assignee:

BioVentrix, Inc. - San Ramon CA
International Classification:

A61F 2/24
US Classification:

600 37
Abstract:

Various methods and devices are provided for reducing the volume of the ventricles of the heart. In one embodiment, a method for reducing the ventricular volume of a heart chamber is provided including the steps of inserting an anchoring mechanism onto dysfunctional cardiac tissue, deploying one or more anchors into the dysfunctional cardiac tissue, raising the dysfunctional cardiac tissue using the anchors, and securing the anchors to hold the dysfunctional cardiac tissue in place. Further, a device for reducing the volume of the ventricles of a heart chamber is provided where the device has one or more clips for placement on dysfunctional cardiac tissue of a heart, one or more anchors for deployment and securement into the dysfunctional cardiac tissue, and a lifting mechanism for raising the one or more anchors and the dysfunctional cardiac tissue.

Method And Device For Treating Dysfunctional Cardiac Tissue
view source
US Patent:

20190343637, Nov 14, 2019
Filed:

May 15, 2019
Appl. No.:

16/413269
Inventors:

- San Ramon CA, US
Lon Annest - New York NY, US
Robert O'Reilly - Lafayette CA, US
Assignee:

BioVentrix, Inc. - San Ramon CA
International Classification:

A61F 2/24
A61B 17/064
A61B 17/04
A61B 17/068
A61B 17/122
A61B 17/128
A61B 17/00
Abstract:

Various methods and devices are provided for reducing the volume of the ventricles of the heart. In one embodiment, a method for reducing the ventricular volume of a heart chamber is provided including the steps of inserting an anchoring mechanism onto dysfunctional cardiac tissue, deploying one or more anchors into the dysfunctional cardiac tissue, raising the dysfunctional cardiac tissue using the anchors, and securing the anchors to hold the dysfunctional cardiac tissue in place. Further, a device for reducing the volume of the ventricles of a heart chamber is provided where the device has one or more clips for placement on dysfunctional cardiac tissue of a heart, one or more anchors for deployment and securement into the dysfunctional cardiac tissue, and a lifting mechanism for raising the one or more anchors and the dysfunctional cardiac tissue.

Method And Device For Treating Dysfunctional Cardiac Tissue
view source
US Patent:

20160262891, Sep 15, 2016
Filed:

Feb 12, 2016
Appl. No.:

15/043274
Inventors:

- San Ramon CA, US
Lon Annest - New York NY, US
Robert O'Reilly - Lafayette CA, US
Assignee:

BioVentrix, Inc. - San Ramon CA
International Classification:

A61F 2/24
A61B 17/068
A61B 17/064
Abstract:

Various methods and devices are provided for reducing the volume of the ventricles of the heart. In one embodiment, a method for reducing the ventricular volume of a heart chamber is provided including the steps of inserting an anchoring mechanism onto dysfunctional cardiac tissue, deploying one or more anchors into the dysfunctional cardiac tissue, raising the dysfunctional cardiac tissue using the anchors, and securing the anchors to hold the dysfunctional cardiac tissue in place. Further, a device for reducing the volume of the ventricles of a heart chamber is provided where the device has one or more clips for placement on dysfunctional cardiac tissue of a heart, one or more anchors for deployment and securement into the dysfunctional cardiac tissue, and a lifting mechanism for raising the one or more anchors and the dysfunctional cardiac tissue.